Clinical Trial Search

Primary: Posterior Capsule Opacification (PCO) — 3.0; 1.9 units on a scale (0-10)

Primary: Percentage Change in Volume of the Masseter Muscle From Baseline to 12 Weeks After Treatment With Botulinum Toxin A — 21.4 percentage reduction in masseter volume

Primary: Neck Pain Rating Neck Disability Index (NDI) — 13; 7.4; 12.2; 11.2 units on a scale

Primary: Change in Vaginal Pain Scores Using the Defense and Veterans Pain Rating Scale (Visual Analog Scale) Between Bupivacaine Alone Versus Exparel® Following Posterior…

Primary: Number of Participants With Raymond Class I Complete Obliteration at 12 Months — 98 Participants

Primary: Difference in Pain Control When Adding Gabapentin to a Multimodal Pain Management Protocol in Pediatric Post-operative Posterior Spinal Fusion Patients. — 2.46; 3.46…

Primary: Postoperative Pain on a Visual Analogue Pain Scale at One Hour Postoperatively — 4.04; 5.09; 4.4 units on a scale

Primary: Medical Record Review and Treatment Utilization Form — 19; 17 Participants — p=.6469

Primary: Numerical Rating Scale-NRS — 4.50; 3.44 units on a scale — p=0.432

Primary: Change in Pain Intensity in Head/Neck Cancer Area: 10cm Visual Analog Scale (VAS) — -1.4; -0.6; 0.1 change units on a VAS scale

Primary: System Usability Scale (SUS) — 79.6 score on a scale

Primary: Change From Pre-Treatment in Average Pain Intensity on a 0-10 Numerical Rating Scale Immediately Following End of Treatment (Post-Treatment) — -.57; -.61; -.85 score on…

Primary: Feasibility, Assessed by Examining Number of Participants Accrued — 20 Participants

Primary: Postoperative Pain — 1.9; 1.3; 2.0; 1.9 mm

Primary: Change in Quantitative Pain Testing Following Active TMS Compared to Baseline — 1.4; .3 Change from Baseline (degrees C) — p=.83